Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial

  • Tripathy, D.

  • University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, NC8.106, Dallas, TX 75390-8852, USA

E-mail: [email protected]

Annals of Oncology 16(3):p 513, March 2005.
Copyright © 2005 The European Society for Medical Oncology